Thermo Fisher Scientific Inc (NYSE:TMO) Position Lowered by Sii Investments Inc. WI

Sii Investments Inc. WI cut its stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 30.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,952 shares of the medical research company’s stock after selling 1,320 shares during the period. Sii Investments Inc. WI’s holdings in Thermo Fisher Scientific were worth $456,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of the stock. BB&T Securities LLC increased its stake in shares of Thermo Fisher Scientific by 4.4% in the first quarter. BB&T Securities LLC now owns 89,837 shares of the medical research company’s stock valued at $13,798,000 after buying an additional 3,819 shares in the last quarter. Toronto Dominion Bank increased its stake in shares of Thermo Fisher Scientific by 53.5% in the first quarter. Toronto Dominion Bank now owns 107,099 shares of the medical research company’s stock valued at $16,450,000 after buying an additional 37,307 shares in the last quarter. Tompkins Financial Corp increased its stake in shares of Thermo Fisher Scientific by 0.8% in the first quarter. Tompkins Financial Corp now owns 5,183 shares of the medical research company’s stock valued at $733,000 after buying an additional 40 shares in the last quarter. Huntington National Bank increased its stake in shares of Thermo Fisher Scientific by 6.9% in the first quarter. Huntington National Bank now owns 186,907 shares of the medical research company’s stock valued at $28,708,000 after buying an additional 12,025 shares in the last quarter. Finally, Advisors Asset Management Inc. increased its stake in shares of Thermo Fisher Scientific by 1.1% in the first quarter. Advisors Asset Management Inc. now owns 66,308 shares of the medical research company’s stock valued at $10,185,000 after buying an additional 735 shares in the last quarter. Institutional investors own 87.15% of the company’s stock.

Shares of Thermo Fisher Scientific Inc (NYSE TMO) traded up 0.86% on Friday, reaching $173.21. 454,571 shares of the company traded hands. The company has a market capitalization of $67.57 billion, a P/E ratio of 30.18 and a beta of 1.06. The firm’s 50 day moving average is $176.85 and its 200 day moving average is $165.24. Thermo Fisher Scientific Inc has a one year low of $139.07 and a one year high of $182.87.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The firm had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.92 billion. During the same quarter in the previous year, the business posted $2.03 earnings per share. The business’s revenue for the quarter was up 10.2% on a year-over-year basis. Analysts expect that Thermo Fisher Scientific Inc will post $9.24 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be given a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date of this dividend is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio is presently 10.45%.

COPYRIGHT VIOLATION NOTICE: “Thermo Fisher Scientific Inc (NYSE:TMO) Position Lowered by Sii Investments Inc. WI” was originally posted by Community Financial News and is the property of of Community Financial News. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this news story can be viewed at https://www.com-unik.info/2017/08/11/thermo-fisher-scientific-inc-nysetmo-position-lowered-by-sii-investments-inc-wi.html.

Several equities research analysts have recently commented on TMO shares. Cantor Fitzgerald started coverage on shares of Thermo Fisher Scientific in a research note on Thursday, May 18th. They issued an “overweight” rating and a $194.00 target price on the stock. Barclays PLC set a $175.00 target price on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a research note on Wednesday, April 26th. Cowen and Company restated an “outperform” rating and issued a $185.00 target price (up previously from $175.00) on shares of Thermo Fisher Scientific in a research note on Saturday, April 29th. Citigroup Inc. restated a “buy” rating and issued a $201.00 target price (up previously from $182.00) on shares of Thermo Fisher Scientific in a research note on Monday, July 10th. Finally, BidaskClub upgraded shares of Thermo Fisher Scientific from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, July 11th. One analyst has rated the stock with a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the company’s stock. Thermo Fisher Scientific currently has an average rating of “Buy” and a consensus price target of $188.56.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 20,000 shares of Thermo Fisher Scientific stock in a transaction dated Thursday, June 1st. The stock was sold at an average price of $172.79, for a total value of $3,455,800.00. Following the transaction, the chief executive officer now owns 269,279 shares in the company, valued at $46,528,718.41. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Stephen Williamson sold 2,500 shares of Thermo Fisher Scientific stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $176.26, for a total value of $440,650.00. Following the completion of the transaction, the chief financial officer now owns 37,790 shares in the company, valued at approximately $6,660,865.40. The disclosure for this sale can be found here. In the last quarter, insiders sold 27,188 shares of company stock worth $4,702,223. Company insiders own 0.49% of the company’s stock.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

What are top analysts saying about Thermo Fisher Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit